Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
- PMID:29891526
- PMCID: PMC9440150
- DOI: 10.6004/jnccn.2018.0055
Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
Abstract
This selection from the NCCN Guidelines for Merkel Cell Carcinoma (MCC) focuses on areas impacted by recently emerging data, including sections describing MCC risk factors, diagnosis, workup, follow-up, and management of advanced disease with radiation and systemic therapy. Included in these sections are discussion of the new recommendations for use of Merkel cell polyomavirus as a biomarker and new recommendations for use of checkpoint immunotherapies to treat metastatic or unresectable disease. The next update of the complete version of the NCCN Guidelines for MCC will include more detailed information about elements of pathology and addresses additional aspects of management of MCC, including surgical management of the primary tumor and draining nodal basin, radiation therapy as primary treatment, and management of recurrence.
Copyright © 2018 by the National Comprehensive Cancer Network.
References
- Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol 2005;89:1–4. - PubMed
- Reichgelt BA, Visser O. Epidemiology and survival of Merkel cell carcinoma in the Netherlands. a population-based study of 808 cases in 1993–2007. Eur J Cancer 2011;47:579–585. - PubMed
- Lyhne D, Lock-Andersen J, Dahlstrom K, et al. Rising incidence of Merkel cell carcinoma. J Plast Surg Hand Surg 2011;45:274–280. - PubMed
- Santamaria-Barria JA, Boland GM, Yeap BY, et al. Merkel cell carcinoma: 30-year experience from a single institution. Ann Surg Oncol 2013;20:1365–1373. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical